A method for assaying the sensitivity of Drosophila replication checkpoint mutants to anti-cancer and DNA-damaging drugs. [electronic resource]
Producer: 20030410Description: 881-9 p. digitalISSN:- 0831-2796
- Animals
- Antineoplastic Agents -- pharmacology
- Cell Cycle -- drug effects
- Cell Cycle Proteins -- genetics
- Checkpoint Kinase 1
- Cisplatin -- pharmacology
- Cytarabine -- pharmacology
- DNA Damage
- DNA Replication -- drug effects
- DNA-Binding Proteins
- Drosophila -- drug effects
- Drosophila Proteins -- genetics
- Female
- Genes, Insect -- drug effects
- Hydroxyurea -- pharmacology
- Male
- Methyl Methanesulfonate -- pharmacology
- Mutation
- Nuclear Proteins
- Paraquat -- pharmacology
- Protein Kinases -- genetics
- Protein Serine-Threonine Kinases
- Protein-Tyrosine Kinases -- genetics
- Schizosaccharomyces pombe Proteins
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.